Alyeska Investment Group
SONN icon

Alyeska Investment Group’s Sonnet BioTherapeutics SONN Stock Holding History

Alyeska Investment Group’s Portfolio SONN Stock Details SONN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,408
Closed -$343K – 577
2023
Q1 		$343K Buy
+5,408
New +$343K ﹤0.01% 398